ProShares Ultra Nasdaq Biotechnology BIB | NASDAQ
BIB last paid $0.0413 a share on Sep 29, and returned 42.2% over 12 months with distributions counted. · 1-year total return +42.2% · Track BIB in a free portfolio
Company Overview:
10 Year BIB Performance Metrics:
BIB Dividend Payments & Yield
BIB Dividends Info:
Projected Future Returns & Dividends for BIB
Based on past 10-year performance, here are BIB growth metrics:
Share price CAGR of +8.56%
Dividend CAGR of +22.35%
Using BIB CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| BIB (DRIP) | BIB - No DRIP | |
|---|---|---|
| Current Price | $53.21 | $53.21 |
| Start Shares | 187.93 | 187.93 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 198.82 | 187.93 |
| Dividends Payment | $0.31 | $0.31 |
| Annual Dividends | $247 | $233 |
| Yield on cost | 2.47% | 2.33% |
| Share Price | $120.94 | $120.94 |
| Total Dividends | $933 | $905 |
| Final Value | $24,046 | $23,635 |
NOTE: Above numbers are our estimate based on BIB's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Company Info
ProShares Ultra Nasdaq Biotechnology (BIB) had its IPO on 2010-04-07, and is traded on NASDAQ stock exchange.
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
BIB website: https://www.proshares.com/funds/bib.html
DCF model unavailable for BIB — no fundamentals on file (ETFs and funds are not modelable).
